logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
Showing 1 - 20 of 27 Items
Showing 1 - 20 of 27 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

Ambulatory Multi-Drug Resistant Tuberculosis Treatment Outcomes in a Cohort of HIV-Infected Patients in a Slum Setting in Mumbai, India

Isaakidis P, Cox HS, Varghese B, Montaldo C, Da Silva E,  et al.
2011-12-01 • PLOS One
2011-12-01 • PLOS One
India carries one quarter of the global burden of multi-drug resistant TB (MDR-TB) and has an estimated 2.5 million people living with HIV. Despite this reality, provision of treatment f...
Journal Article
|
Short Report

Treating All Multidrug-Resistant Tuberculosis Patients, Not Just Bacteriologically Confirmed Cases

Das M, Isaakidis P, Van der Bergh R, Kumar AMV, Sharath BN,  et al.
2016-06-21 • Public Health Action
2016-06-21 • Public Health Action
Journal Article
|
Research

Implementing the Xpert MTB/RIF diagnostic test for tuberculosis and rifampicin resistance: outcomes and lessons learned in 18 countries

Ardizzoni E, Fajardo E, Saranchuk P, Casenghi M, Page AL,  et al.
2015-12-15 • PLOS One
2015-12-15 • PLOS One
BACKGROUND
The Xpert® MTB/RIF (Xpert) is an automated molecular test for simultaneous detection of tuberculosis (TB) and rifampicin resistance, recommended by the World Health Organi...
Journal Article
|
Research

CMV retinitis in China and SE Asia: the way forward

Heiden D, Saranchuk P
2011-11-24 • BMC Infectious Diseases
2011-11-24 • BMC Infectious Diseases
AIDS-related CMV retinitis is a common clinical problem in patients with advanced HIV/AIDS in China and Southeast Asia. The disease is causing blindness, and current clinical management,...
Journal Article
|
Research

Out-of-pocket costs of AIDS care in China: are free antiretroviral drugs enough?

Moon S, Van Leemput L, Durier N, Jambert E, Dahmane A,  et al.
2008-09-01 • AIDS Care
2008-09-01 • AIDS Care
Financial access to HIV care and treatment can be difficult for many people in China, where the government provides free antiretroviral drugs but does not cover the cost of other medical...
Journal Article
|
Letter

We urge WHO to act on cytomegalovirus retinitis

Heiden D, Saranchuk P, Tun NL, Audoin B, Cohn J,  et al.
2014-02-01 • Lancet Global Health
2014-02-01 • Lancet Global Health
Journal Article
|
Letter

Outcomes in Adolescents Undergoing Treatment for Drug-Resistant Tuberculosis in Mumbai

Isaakidis P, Das M, Saranchuk P
2015-07-14 • Archives of Pediatric Infectious Diseases
2015-07-14 • Archives of Pediatric Infectious Diseases
Journal Article
|
Research

Infection control in households of drug-resistant tuberculosis patients co-infected with HIV in Mumbai, India

Albuquerque T, Isaakidis P, Das M, Saranchuk P, Andries A,  et al.
2014-03-21 • Public Health Action
2014-03-21 • Public Health Action
Background: Mumbai has a population of 21 million, and an increasingly recognised epidemic of drug-resistant tuberculosis (DR-TB). Objective: To describe TB infection control (IC) measur...
Journal Article
|
Research

Second-line failure and first experience with third-line antiretroviral therapy in Mumbai, India

Khan S, Das M, Andries A, Deshpande A, Mansoor H,  et al.
2014-07-30 • Global Health Action
2014-07-30 • Global Health Action
There are limited data on the failure of second-line antiretroviral therapy (ART) and the use of third-line ART in people living with HIV in resource-limited settings. Since 2011, the Mé...
Journal Article
|
Research

Evaluation of a diagnostic algorithm for smear-negative pulmonary tuberculosis in HIV-infected adults

Saranchuk P, Boulle AM, Hilderbrand K, Coetzee D, Bedelu M,  et al.
2007-07-01 • South African Medical Journal
2007-07-01 • South African Medical Journal
OBJECTIVES: To evaluate the diagnostic accuracy of and reduction in diagnostic delay attributable to a clinical algorithm used for the diagnosis of smear-negative pulmonary tuberculosis ...
Journal Article
|
Commentary

Feasibility and benefits of scaling up antiretroviral treatment provision with the 2010 WHO antiretroviral therapy guidelines in rural Lesotho

Bygrave H, Saranchuk P, Makakole L, Ford NP
2012-07-31 • International Health
2012-07-31 • International Health
Journal Article
|
Research

Self-Administered Tuberculosis Treatment Outcomes in a Tribal Population on the Indo-Myanmar Border, Nagaland, India

Das M, Isaakidis P, Shenoy R, Anicete R, Sharma H,  et al.
2014-09-26 • PLOS One
2014-09-26 • PLOS One
Multiple strategies are being adopted by national tuberculosis (TB) programmes to achieve universal coverage of tuberculosis treatment. However, populations living in 'hard-to-reach' are...
Journal Article
|
Commentary

Training clinicians treating HIV to diagnose cytomegalovirus retinitis

Heiden D, Tun NL, Maningding E, Heiden M, Rose-Nussbaumer J,  et al.
2014-09-22 • Bulletin of the World Health Organization
2014-09-22 • Bulletin of the World Health Organization
PROBLEM
Acquired immunodeficiency syndrome (AIDS)-related cytomegalovirus (CMV) retinitis continues to be a neglected source of blindness in resource-poor settings. The main issue is...
Journal Article
|
Research

Ocular inflammatory disease and ocular tuberculosis in a cohort of patients co-infected with HIV and multidrug-resistant tuberculosis in Mumbai, India: a cross-sectional study

mehta, Mansoor H, Khan S, Saranchuk P, Isaakidis P
2013-05-20 • BMC Infectious Diseases
2013-05-20 • BMC Infectious Diseases
The prevalence and the patterns of ocular inflammatory disease and ocular tuberculosis (TB) are largely undocumented among Multidrug Resistant TB (MDR-TB) patients co-infected with Human...
Journal Article
|
Letter

Viral load for HIV treatment failure management: a report of eight drug-resistant tuberculosis cases co-infected with HIV requiring second-line antiretroviral treatment in Mumbai, India

Andries A, Das M, Isaakidis P, Saranchuk P
2013-12-01 • American Journal of Tropical Medicine and Hygiene
2013-12-01 • American Journal of Tropical Medicine and Hygiene
Journal Article
|
Review

Burden of HIV-related cytomegalovirus retinitis in resource-limited settings: a systematic review

Ford NP, Shubber Z, Saranchuk P, Pathai S, Durier N,  et al.
2013-07-29 • Clinical Infectious Diseases
2013-07-29 • Clinical Infectious Diseases
BACKGROUND
Cytomegalovirus (CMV) is a late-stage opportunistic infection in people living with human immunodeficiency virus (HIV)/AIDS. Lack of ophthalmological diagnostic skills, la...
Journal Article
|
Research

Resistance Patterns among Multidrug-Resistant Tuberculosis Patients in Greater Metropolitan Mumbai: Trends over Time

Dalal A, Pawaskar A, Das M, Desari R, Prabhudesai P,  et al.
2015-01-21 • PLOS One
2015-01-21 • PLOS One
While the high burden of multidrug-resistant tuberculosis (MDR-TB) itself is a matter of great concern, the emergence and rise of advanced forms of drug-resistance such as extensively dr...
Journal Article
|
Short Report

Antiretroviral treatment outcomes from a nurse-driven, community-supported HIV/AIDS treatment programme in rural Lesotho: observational cohort assessment at two years

Cohen RM, Lynch S, Bygrave H, Eggers E, Vlahakis N,  et al.
2009-10-08 • Journal of the International AIDS Society
2009-10-08 • Journal of the International AIDS Society
ABSTRACT: INTRODUCTION: Lesotho has the third highest HIV prevalence in the world (an adult prevalence of 23.2%). Despite a lack of resources for health, the country has implemented stat...
Journal Article
|
Case Report/Series

Patch-testing for the management of hypersensitivity reactions to second-line anti-tuberculosis drugs: a case report

Khan S, Andries A, Pherwani A, Saranchuk P, Isaakidis P
2014-08-15 • BMC Research Notes
2014-08-15 • BMC Research Notes
BACKGROUND
The second-line anti-tuberculosis drugs used in the treatment of multidrug-resistant tuberculosis often cause adverse events, especially in patients co-infected with the h...
Journal Article
|
Research

Alarming Levels of Drug-Resistant Tuberculosis in HIV-Infected Patients in Metropolitan Mumbai, India

Isaakidis P, Das M, Kumar AMV, Peskett C, Khetarpal M,  et al.
2014-10-21 • PLOS One
2014-10-21 • PLOS One
Drug-resistant tuberculosis (DR-TB) is a looming threat to tuberculosis control in India. However, no countrywide prevalence data are available. The burden of DR-TB in HIV-co-infected pa...